Teal Health's at-home cervical cancer screening device received the FDA Breakthrough Device Designation , recognizing both its strong clinical data a ...

The global anorexiant market is set for significant expansion, with a projected compound annual growth rate (CAGR) of 5.1% over the forecast period, according to a recent study by Future Market ...

For example, in September 2024, Roche launched the cobas Respiratory flex test. This is the first test by Roche using Roche's innovative and proprietary TAGS (Temperature-Activated Generation of ...

NEW YORK – With the launch of two point-of-care molecular assays for sexually transmitted infections, Roche Diagnostics is preparing to enter a new commercial market. The assays run on the firm's ...

Moreover, vulnerable populations often hesitate to provide blood samples; therefore, we used Roche's Cobas B 101 system to measure biochemical values through capillary blood samples, a faster and less ...

Plasma NT-proBNP concentration was measured using an Elecsys proBNP, Cobas E analyser (Roche Diagnostics GmbH, Mannheim, Germany) within a measurable range between 5 and 35 000 pg mL/L. Risk ...

were assessed using an electrochemiluminescence immunoassay system analyzer (Cobas 8000 e801; Roche Diagnostics, Basel, Switzerland). All MRI scans were performed using a clinical 3T MRI system (uMR ...

The o-cresolphthalein complexone and phosphomolybdate ultraviolet (UV) methods were applied to measure calcium and phosphorus levels, respectively, using the Cobas c501 equipment (Roche). The ...

According to Research by SNS Insider, the growth of the liquid biopsy market is driven by significant technological advancements and a growing preference for minimally invasive procedures.Pune, March ...

Teal Health, a women's health company on a mission to eradicate cervical cancer by bringing at-home cervical cancer screening ...